Kelun-Biotech’s Novel CLDN18.2 ADC SKB315 IND in Combination with Tagolizumab Receives NMPA Approval for the First-Line Treatment of Gastric/Gastro-oesophageal Junction Cancer June 12, 2025 — 11:54
Xinhua Silk Road: Parallel Forum on Inclusive Finance and Approaches to New Energy Industrialization Development held in Beijing March 22, 2025 — 20:08
Wingderm® Presents at the 2025 AAD Annual Meeting, Strengthening Its Presence in the North American Market March 11, 2025 — 01:00
Magcubic Disrupts the Smart Projector Market with Affordable Products for Everyone March 11, 2025 — 00:00
Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease November 8, 2024 — 17:45
Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results August 29, 2024 — 14:31
PR Newswire
